Furthermore, increased plasma E-selectin levels (≥32.5 ng/mL), along with P-selectin and L-selectin, were independent predictors for thrombosis in hospitalized COVID-19 subjects [55]. The gene discussed is SELL; the disease is Venous thrombosis.